Shares of Surgical Science Sweden AB (publ) (OTCMKTS:SUSRF – Get Free Report) shot up 6.7% on Friday . The company traded as high as $14.88 and last traded at $14.88. 5,000 shares traded hands during trading, an increase of 100% from the average session volume of 2,500 shares. The stock had previously closed at $13.95.
Surgical Science Sweden AB (publ) Stock Performance
The stock has a 50-day moving average price of $14.14 and a two-hundred day moving average price of $12.83.
Surgical Science Sweden AB (publ) Company Profile
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases.
Recommended Stories
- Five stocks we like better than Surgical Science Sweden AB (publ)
- What Makes a Stock a Good Dividend Stock?
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- Earnings Per Share Calculator: How to Calculate EPS
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- Airline Stocks – Top Airline Stocks to Buy Now
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Receive News & Ratings for Surgical Science Sweden AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgical Science Sweden AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.